Savannah Murphy

Pronouns: She/Her/Hers

​

Languages: English, Spanish

​

Biographical Sketch:

Savannah Murphy has been curious about science since the sixth grade when she was first exposed to the perplexing world of chemistry. Savannah enjoys the complex nature of diseases and the problem-solving abilities needed to tackle them—specifically, the application of chemistry in the human body, and diseases including cancer. Savannah began her academic career as a first-generation college student at Massasoit Community College. There, she received a full STEM scholarship and participated in an on-campus research lab internship.

 

While at Massasoit Community College, she was a part of the Commonwealth Honors Program and Phi Theta Kappa International College Honor Society. Through the honors program, she conducted two independent research projects on the subject matter that she is most passionate about—cancer biology—and presented her work at the Undergraduate Research Conference at the University of Massachusetts Amherst (UMass Amherst).

 

Further, she completed internships focused in organic chemistry clinical research at Boston University (BU), ophthalmology clinical research at BostonSight, and high-grade serous ovarian cancer (HGSOC) clinical research at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS).

 

During the spring of 2023, Savannah graduated with her Associate of Science (AS) in Chemistry and transferred to Northeastern University, where she is currently pursuing Dual Bachelors of Science (BS) in Chemistry and Biology with concentrations in Chemical Biology and Pre-Medical Studies.

 

She is a designated scholar through the American Chemical Society (ACS) and has been selected as a scholar through Blueprint Medicines. Aside from research, Savannah is a Medical Assistant (MA) and has worked at the Division of Medical Oncology at the Beth Israel Deaconess Medical Center (BIDMC). Further, she is an active member of Northeastern University Student Affiliates of the American Chemical Society (NUSAACS); Women's Research Engagement Network (WREN), where she is a WREN scholar and mentor; and TedXNortheasternU.

 

Savannah's approach to science is from a chemical point-of-view integrated with her understanding of biological complexes and systems; complemented by her love of hematology, oncology, and immunology; and her drive for advancements in cancer and other diseases. She strives to bring care to oncology both behind-the-scenes and bedside, as she is passionate about health literacy and patient education, and on her journey to an MD/PhD.​

​

Awards and Honors:

• Student Scholar, Blueprint Medicines and American Chemical Society (ACS), September 2024

• Women's Research Engagement Network (WREN) Scholar, September 2024

• Student Scholar, American Chemical Society (ACS), May 2023

​

Selected Works:

• He, C., Lv, X., Liu, J., Ruan, J., Chen, P., Huang, C., ... & Wang, C. (2024). HPV–YAP1 Oncogenic Alliance Drives Malignant Transformation of Fallopian Tube Epithelial Cells. European Molecular Biology Organization (EMBO) Reports, 1–28. *Served as an author alongside 21 co-authors

• Murphy, S. (2023). Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR): Application to Cancer Biology. Massasoit Community College.

• Murphy, S. (2022). How Potential of Hydrogen (pH) Plays a Role and Effects the Delivery of Anti-Cancer Drugs. Massasoit Community College.